This is best exemplified by the role of AGPAT2 in the development of type 1 congenital generalized lipodystrophy (CGL) and is also manifested by recent studies highlighting the involvement of AGPATs in the physiology and pathology of various tissues and organs. This evidence concerns the gene AGPAT2 and Berardinelli-Seip congenital lipodystrophy.